Tianjin works to help fight COVID-19 worldwide

Tianjin is ramping up efforts to export and donate novel coronavirus testing kits and other supplies to meet increasing overseas demand, amid the surge of COVID-19 cases outside China.

A batch of COVID-19 Antibody Diagnostic Kits - enough for 13,500 people - have been approved by Tianjin’s customs and will be exported to Switzerland and other areas soon.

A total of seven types of kit are included. They have been developed and manufactured by Bioscience (Tianjin) Diagnostic Technology Company. The serial serology kit products received EU CE (French for ‘European Conformity’) certification on March 9, the first of their type in China to achieve this.

The products can detect either IgM or IgG antibodies, or both, according to different types, in human serum, plasma and whole blood samples in as little as 15 minutes, effectively accelerating on-site screening of suspected patients.

Easy to use, fast, and highly accurate, these kits are suitable for large-scale testing.

"The virus knows no borders, and all countries should join together to curb its spread,” said Luan Dawei, president of the company. “We hope to make full use of Bioscience’s technological expertise to provide solutions for meeting the demand from countries and regions facing COVID-19 challenges, and lacking sufficient and efficient testing capabilities."

Establishing a special team, Tianjin customs facilitated the export of these bioproducts through pre-emptive planning, which saved time when carrying out their strict inspections.

A branch of China Construction Bank (CCB) in Tianjin facilitated sending nearly $20,000 worth of anti-epidemic materials to Singapore by matching businesses using big data and cloud computing.

Aside from prevention and control supplies, Tianjin companies have also ramped up efforts amid COVID-19 to meet overseas orders on time, supporting the operation of the global supply chain and cushioning economic losses of partner companies worldwide.